Showing results (71-80 of 776) with videos related to
Sort By:
Pageof 78
Kidney International|July 24, 2009
V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reductionNorberto Perico, Carla Zoja, Daniela Corna, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 25, 2005
High-performance liquid chromatography with ultraviolet detection for therapeutic drug monitoring of everolimusSara Baldelli, Stefano Murgia, Simona Merlini, et al.Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Basiliximab combined with low-dose rabbit anti-human thymocyte globulin: a possible further step toward effective and minimally toxic T cell-targeted therapy in kidney transplantationPiero Ruggenenti, Igor Codreanu, Paolo Cravedi, et al.The American Journal of Pathology|October 8, 2013
Nature and mediators of parietal epithelial cell activation in glomerulonephritides of human and ratPaola Rizzo, Norberto Perico, Elena Gagliardini, et al.Lancet (London, England)|June 4, 2013
Kidney failure: aims for the next 10 years and barriers to successGiuseppe Remuzzi, Ariela Benigni, Fredric O Finkelstein, et al.Nephron|December 13, 2016
Conversion from Brand-Name Neoral to the Generic Ciqorin in Stable Renal Transplant RecipientsMonica Cortinovis, Eliana Gotti, Matias Trillini, et al.Therapeutic Drug Monitoring|October 14, 2006
Mycophenolic acid formulation affects cyclosporine pharmacokinetics in stable kidney transplant recipientsDario Cattaneo, Simona Merlini, Sara Baldelli, et al.Pharmacogenomics|October 11, 2007
C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantationSara Baldelli, Simona Merlini, Norberto Perico, et al.Nephron. Clinical Practice|June 9, 2005
Cyclosporine prolongs delayed graft function in kidney transplantation: are rabbit anti-human thymocyte globulins the answer?Paolo Cravedi, Igor Codreanu, Antonio Satta, et al.Journal of the American Society of Nephrology : JASN|October 7, 2004
Targeted deletion of angiotensin II type 1A receptor does not protect mice from progressive nephropathy of overload proteinuriaAriela Benigni, Daniela Corna, Carla Zoja, et al.Pageof 78